Research progress on ophthalmological administration routes and pharmacokinetics of nerve growth factor
Author:
  • Article
  • | |
  • Metrics
  • |
  • Reference [48]
  • |
  • Related [20]
  • | | |
  • Comments
    Abstract:

    Nerve growth factor(NGF)is one of the most important active protein acting on the nervous system, it is applicated widely in ophthalmology, the administration route includes systemic drug administration and local drug administration. Compared to systemic drug administration, local drug administration is targeted, it is more effective to achieve the necessary concentration in eyes and it reduces the risk of side effects. Local drug administration has been a common treatment method in eye diseases. With the development of administration route, corresponding pharmacokinetic researches have received the concern. This review provides a reference for the study on ophthalmological administration routes and pharmacokinetics of nerve growth factor.

    Reference
    1 Levi-Montalcini R.The nerve growth factor 35 years later.Science 1987; 237(4819):1154-1162
    2 Aloe L,Calzà L.NGF and related molecules in health and disease.Progr Brain Res 2004; 146(32):515-522
    3 Carmignoto G,Maffei L,Candeo P,et al.Effect of NGF on the survival of rat retinal ganglion cells following optic nerve section.J Neurosci 1989; 9(4):1263-1272
    4 Lambiase A,Mantelli F,Sacchetti M,et al.Clinical applications of NGF in ocular diseases.Arch Ital Biol 2011; 149(2):283-292
    5周丽霞,白嵘.神经生长因子与缺血性视神经病变.航空航天医药2010; 21(6):999-1000
    6黄辰晔,杨柳.神经生长因子治疗糖尿病视网膜病变初探.国际眼科杂志2012; 12(9):1654-1658
    7王玉国,张丹丹.鼠神经生长因子治疗视神经挫伤的研究.航空航天医药2010; 21(4):435-436
    8 Lee SB,Geroski DH,Prausnitz MR,et al.Drug delivery through the sclera:effects of thickness,hydration,and sustained release systems.Exp Eye Res 2004; 78(3):599-607
    9 Kearns VR,Williams RL.Drug delivery systems for the eye.Expert Rev Med Devices 2009; 6(3):277-290
    10 Urtti A,Rouhiainen H,Kaila T,et al.Controlled ocular timolol delivery:systemic absorption and intraocular pressure effects in humans.Pharm Res 1994; 11(9):1278-1282
    11 Charles JB,Ganthier R Jr,Wilson MR,et al.Use of bioerodible polymers impregnated with mitomycin in glaucoma filtration surgery in rabbits.Ophthalmology 1991; 98(4):503-508
    12 Chang SC,Chien DS,Bundgaard H,et al.Relative effectiveness of prodrug and viscous solution approaches in maximizing the ratio of ocular to systemic absorption of topically applied timolol.Exp Eye Res 1988; 46(1):59-69
    13 Choonara YE,Pillay V,Danckwerts MP,et al.A review of implantable intravitreal drug delivery technologies for the treatment of posterior segment eye diseases.J Pharm Sci 2010; 99(5):2219-2239
    14马健利,孙先勇,张杰,等.鼠神经生长因子对糖尿病性视神经病变的疗效分析.国际眼科杂志2012; 12(10):1958-1960
    15谢溱,沈心亮,辛芳.ELISA法对神经生长因子在大鼠体内药代动力学的研究.中国药理学通报1999; 15(3):268-270
    16 Tria MA,Fusco M,Vantini G,et al.Pharmacokinetics of nerve growth factor(NGF)following different routes of administration to adult rats.Exp Neurol 1994; 127(2):178-183
    17 Laties AM,Rapoport S.The blood-ocular barriers under osmotic stress.Studies on the freeze-dried eye.Arch Ophthalmol 1976; 94(7):1086-1091
    18 Rapoport SI.Osmotic opening of the blood-brain barrier: principles, mechanism,and therapeutic applications.Cell Mol Neurobiol 2000; 20(2):217-230
    19 Foulds WS,Moseley H,Eadie A,et al.Vitreal, retinal, and pigment epithelial contribution to the posterior blood-ocular barrier.Trans Ophthalmol Soc U K 1980; 100(3):341-342
    20 Cunha-Vaz J.The blood-ocular barriers.Surv Ophthalmol 1979; 23(5):279-296
    21 Lambiase A,Aloe L,Centofanti M,et al.Experimental and clinical evidence of neuroprotection by nerve growth factor eye drops:Implications for glaucoma.Proc Natl Acad Sci USA 2009; 106(32):13469-13474
    22 Colafrancesco V,Coassin M,Rossi S,et al.Effect of eye NGF administration on two animal models of retinal ganglion cells degeneration.Ann Ist Super Sanita 2011; 47(3):284-289
    23 Thomas ER,Wang J,Ege E,et al.Intravitreal triamcinolone acetonide concentration after subtenon injection.Am J Ophthalmol 2006; 142(5):860-861
    24 Lambiase A,Tirassa P,Micera A,et al.Pharmacokinetics of conjunctivally applied nerve growth factor in the retina and optic nerve of adult rats.Invest Ophthalmol Vis Sci 2005; 46(10):3800-3806
    25陈乔,杨红,陈建斌.球周注射大剂量曲安奈德后眼内药物浓度与安全性实验.医药导报 2007; 26(7):713-716
    26夏清艳,潘晓波.球后注射鼠神经生长因子治疗视神经萎缩的临床疗效观察.医学信息 2011; 7:3255-3256
    27 Claro C,Ruiz R,Cordero E,et al.Determination and pharmacokinetic profile of liposomal foscarnet in rabbit ocular tissues after intravitreal administration.Exp Eye Res 2009; 88(3):528-534
    28 Douglas LC,Yi NY,Davis JL,et al.Ocular toxicity and distribution of subconjunctival and intravitreal rapamycin in horses.J Vet Pharmacol Ther 2008; 31(6):511-516
    29 Hu T,Le Q,Wu Z,et al.Determination of doxorubicin in rabbit ocular tissues and pharmacokinetics after intravitreal injection of a single dose of doxorubicin-loaded poly-beta-hydroxybutyrate microspheres.J Pharm Biomed Anal 2007; 43(1):263-269
    30 Gupta SK,Velpandian T,Dhingra N,et al.Intravitreal pharmacokinetics of plain and liposome-entrapped fluconazole in rabbit eyes.J Ocul Pharmacol Ther 2000; 16(6):511-518
    31 Beer PM,Bakri SJ,Singh RJ,et al.Intraocular concentration and pharmacokinetics of triamcinolone acetonide after a single intravitreal injection.Ophthalmology 2003; 110(4):681-686
    32 Ahn J,Kim H,Woo SJ,et al.Pharmacokinetics of intravitreally injected bevacizumab in vitrectomized eyes.J Ocul Pharmacol Ther 2013; 29(7):612-618
    33 Damico FM,Scolari MR,Ioshimoto GL,et al.Vitreous pharmacokinetics and electroretinographic findings after intravitreal injection of acyclovir in rabbits.Clinics 2012; 67(8):931-937
    34 Sivilia S,Giuliani A,Fernández M,et al.Intravitreal NGF administration counteracts retina degeneration after permanent carotid artery occlusion in rat.BMC Neurosci 2009; 10(52):1-14
    35 Xie Y,Ye LY,Zhang XB,et al.Transport of nerve growth factor encapsulated into liposomes across the blood-brain barrier:in vitro and in vivo studies.J Control Release 2005; 105(1-2):106-119
    36 Angeletti RH,Aneletti PU,Levi-Montalcini R.Selective accumulation of(125 I)labelled nerve growth factor in sympathetic ganglia.Brain Res 1972; 46(13):421-425
    37姜国华,刘忠敏.同位素示踪法研究125I在小鼠体内的吸收、分布及排泄.研究报告2012; 18(1):10-13
    38 Krohne TU,Liu Z,Holz FG,et al.Intraocular pharmacokinetics of ranibizumab following a single intravitreal injection in humans.Am J Ophthalmol 2012; 154(4):682-686
    39 Nomoto H,Shiraga F,Kuno N,et al.Pharmacokinetics of bevacizumab after topical,subconjunctival,and intravitreal administration in rabbits.Invest Ophthalmol Vis Sci 2009; 50(10):4807-4813
    40 Luk YO,Chen WY,Wong WJ,et al.Treatment of focal cerebral ischemia with liposomal nerve growth factor.Drug Deliv 2004; 11(5):319-324
    41刘丹岩,马景学,安建斌,等.苦参碱聚乳酸微球玻璃体腔内注射的药代动力学研究.眼科研究2009; 27(10):833-837
    42 Zhang LH,Li Y,Zhang C,et al .Pharmacokinetics and tolerance study of intravitreal injection of dexamethasone-loaded nanoparticles in rabbits.Int J Nanomedicine 2009; 4(1):175-183
    43 Inoue M,Takeda K,Morita K,et al.Vitreous concentrations of triamcinolone acetonide in human eyes after intravitreal or subtenon injection.Am J Ophthalmol 2004; 138(6):1046-1048
    44解云,刘子修,周玲,等.曲安奈德离子导入在兔眼房水中的药代动力学研究初探.中国药物与临床2011; 11(2):137-139
    45姜国辉,唐刚华,张云,等.神经生长因子的药代动力学研究.中国药学杂志2000; 35(3):181-184
    46黄才国,魏善建,姜华,等.神经生长因子在小鼠体内的动力学、组织分布和排泄实验.第二军医大学学报2001; 22(1):65-67
    47刘丹宁,阴正勤.两种不同注射方法眼局部注射鼠神经生长因子后兔眼内药物分布.中华眼底病杂志2009; 25(6):470-473
    48陈慷,郭希让,鲍玉洲,等.大鼠眼玻璃体内注射神经生长因子的药代动力学研究.眼科研究2003; 21(3):267-268
    Cited by
    Comments
    Comments
    分享到微博
    Submit
Get Citation

Ai-Neng Zeng, Li-Na Huang, Fan-Yin Wang. ,/et al.Research progress on ophthalmological administration routes and pharmacokinetics of nerve growth factor. Guoji Yanke Zazhi( Int Eye Sci) 2014;14(4):637-640

Copy
Share
Article Metrics
  • Abstract:1761
  • PDF: 1420
  • HTML: 0
  • Cited by: 0
Publication History
  • Received:January 09,2014
  • Revised:March 11,2014
  • Online: March 24,2014